Trends and influencing factors of ADRs associated with China’s national essential medicines: A time-series analysis based on data from the National ADR Monitoring Network

Author:

Tang Wan1,Chen Hongdou1,Zhang Zixin1,Wu Gang1,Lin Yanquan1

Affiliation:

1. Suqian Hospital of Nanjing Drum-Tower Hospital Group

Abstract

Abstract Objective. To explore the drivers of the increase in adverse drug reactions (ADRs) associated with drugs in China's list of essential medicines and to analyse the ADR impact of the number of visits, based on the recorded annual increase in ADRs associated with essential medicines in China, to provide a reliable theoretical basis for further analysis and optimization of the safety of essential drugs. Methods. A time-series analysis was conducted based on the ADR data for essential medicines from 2011 to 2020 collected from the National ADR Monitoring Center. The relationship between the ADRs associated with essential medicines and the number of visits was explored by means of a vector autoregressive model, Granger causality test, impulse response analysis, variance analysis and other quantitative analysis methods. Results. There was a long-term cointegration relationship and one-way causality between the number of visits and ADRs caused by essential medicines. In the initial stage, the ADR response to the number of visits increased sharply, but with an increase in the number of lag periods, the impact remained basically stable, even showing a slight decreasing trend. Conclusion. The number of visits impacts ADRs caused by essential medicines, but this impact remains basically stable after reaching a certain level. In the long run, the impact may decrease.

Publisher

Research Square Platform LLC

Reference20 articles.

1. 1. Y. Zhao. Research on the National Essential Drugs List of China in 2018[D]. Zhengzhou University, 2019.

2. 2. L. Ye, S. L. Hu, M. Ewen, et al. Eivdence-base study on th affordability of essential drugs in Shanghai[J]. Chinese Health Resources, 2008,11(4):195–196.

3. 3. Y. Zhang, X. Li. Investigation and analysis of availability and affordability of essential medicine in Nanjing based on WHO/ HAI standard survey method[J]. China Pharmacy, 2015,26(30):4188–4191.

4. 4. S. W. Gong, Y. Xu, L. Zhang. Study on Evaluation Indicator System of Drug Accessibility[J]. Chinese Health Economics, 2011,30(5):72–74.

5. 5. X. D. Guan, L. W. Shi. Study on evaluation method for the accessibility of essential medicine in China based on WHO/HAI standardized approach[J]. China Pharmacy, 2013,24(24):2212–2215.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3